Clorox key statistics and ratios

In fiscal 2025, Clorox had a net margin of 11.4%, debt equal to 775.1% of equity and a current ratio of 0.84. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Clorox: financial ratios, annual
Fiscal year	2009Jun 2009	2010Jun 2010	2011Jun 2011	2012Jun 2012	2013Jun 2013	2014Jun 2014	2015Jun 2015	2016Jun 2016	2017Jun 2017	2018Jun 2018	2019Jun 2019	2020Jun 2020	2021Jun 2021	2022Jun 2022	2023Jun 2023	2024Jun 2024	2025Jun 2025	LTMMar 2026
Gross margin	42.7%	44.3%	43.5%	42.1%	42.5%	42.7%	43.6%	45.1%	44.7%	43.7%	43.9%	45.6%	43.6%	35.8%	39.4%	43.0%	45.2%	43.8%
Net margin	10.4%	11.5%	10.6%	9.9%	10.2%	10.1%	10.3%	11.2%	11.7%	13.4%	13.2%	14.0%	9.7%	6.5%	2.0%	3.9%	11.4%	11.2%
Free-cash-flow margin	10.5%	11.8%	9.0%	7.7%	10.4%	11.4%	13.2%	10.5%	10.6%	12.8%	12.6%	19.2%	12.9%	7.5%	12.6%	6.8%	10.7%	5.6%
Return on equity	—	—	—	—	—	—	—	—	167.1%	129.8%	127.6%	128.0%	107.7%	95.6%	38.4%	102.2%	—	—
Return on assets	11.7%	13.2%	12.8%	12.7%	13.2%	13.0%	13.8%	15.0%	15.4%	17.1%	16.1%	16.6%	11.3%	7.4%	2.5%	4.8%	14.3%	12.6%
Asset turnover	1.13	1.15	1.20	1.28	1.30	1.29	1.35	1.33	1.32	1.27	1.22	1.19	1.17	1.14	1.22	1.21	1.26	1.13
Current ratio	0.61	0.91	0.94	0.67	1.25	0.85	1.02	0.95	0.84	1.09	0.91	1.42	0.89	0.97	0.95	1.03	0.84	0.84
Debt to equity	—	>999%	—	—	>999%	>999%	>999%	778.5%	405.0%	342.0%	480.0%	306.2%	677.4%	487.6%	>999%	757.6%	775.1%	—
Effective tax rate	—	—	—	—	—	34.5%	34.2%	34.1%	31.9%	21.9%	19.9%	20.8%	20.1%	22.4%	32.4%	26.6%	23.6%	22.1%
R&D as % of revenue	2.2%	2.3%	2.2%	2.2%	2.3%	2.3%	2.4%	2.4%	2.3%	2.2%	2.2%	2.2%	2.0%	1.9%	1.9%	1.8%	1.7%	1.7%
SG&A as % of revenue	13.6%	14.0%	14.1%	14.6%	14.1%	13.6%	14.1%	14.0%	13.6%	13.7%	13.8%	14.4%	13.7%	13.4%	16.0%	16.5%	15.8%	15.7%
Capital spending as % of revenue	3.8%	3.8%	4.4%	3.5%	3.4%	2.5%	2.2%	3.0%	3.9%	3.2%	3.3%	3.8%	4.5%	3.5%	3.1%	3.0%	3.1%	2.9%
Free cash flow ÷ net income	100.9%	102.5%	84.4%	77.6%	102.3%	112.9%	129.1%	93.5%	90.4%	95.0%	95.9%	137.6%	133.1%	115.8%	624.2%	172.5%	94.0%	50.3%
Dividends ÷ net income	48.0%	46.8%	54.4%	58.2%	58.6%	65.9%	66.4%	61.4%	58.8%	54.7%	59.8%	56.8%	78.6%	123.6%	391.3%	212.5%	74.3%	79.6%
Dividends and buybacks ÷ free cash flow	47.6%	69.9%	203.8%	128.6%	79.1%	99.7%	109.3%	107.6%	93.8%	92.2%	146.4%	60.4%	154.8%	111.4%	62.7%	123.2%	122.7%	245.5%

US$ thousands unless shown otherwise. Fiscal quarters.

Clorox: financial ratios, quarterly
Quarter	2025 Q1Sept 2024	2025 Q2Dec 2024	2025 Q3Mar 2025	2025 Q4Jun 2025	2026 Q1Sept 2025	2026 Q2Dec 2025	2026 Q3Mar 2026	2027 Q1Sept 2026
Gross margin	45.8%	43.8%	44.6%	46.5%	41.7%	43.2%	43.2%	40.4%
Net margin	5.6%	11.4%	11.2%	16.7%	5.6%	9.4%	11.2%	8.9%
Free-cash-flow margin	10.3%	7.5%	14.0%	11.0%	4.0%	16.1%	−9.9%	5.5%
Current ratio	1.00	0.94	0.74	0.84	0.76	0.74	0.84	0.65
Debt to equity	>999%	—	>999%	773.8%	—	—	—	—
R&D as % of revenue	1.8%	1.8%	1.6%	1.6%	2.0%	1.7%	1.6%	1.5%
SG&A as % of revenue	15.9%	16.6%	16.0%	14.9%	19.4%	15.7%	13.7%	15.2%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

0 of 3 checks passed · September 30, 2026

What it owns · $7.8bn

Short-term assets $1.9bnLonger-term assets $5.9bn

What it owes, and who funded it · $7.7bn

Short-term liabilities $3.0bnLonger-term liabilities $4.8bnShareholders' equity $-39m

Short-term assets cover short-term liabilities $1.9bn of assets due within a year against $3.0bn of liabilities due within a year.
Short-term assets cover long-term liabilities $1.9bn short-term assets against $4.8bn of longer-dated liabilities.
More cash than debt $184m of cash against $4.0bn of debt.
Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Clorox's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

67 /100

Moderate moat

How hard Clorox's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

Returns on capital 20 / 20

Net income has been a median 13.5% of total assets over 10 years.
Pricing power 14 / 20

Gross margin has been a median 44.0%, moving by 3.2 percentage points (standard deviation) across 10 years.
Durability 4 / 20

Net margin has been a median 11.2%; its worst year was 1.0%.
Cash conversion 16 / 20

Free cash flow was positive in 10 of 10 years, at a median 11.6% of revenue.
Discipline 18 / 20

The diluted share count fell 4.1% over five years; stock-based pay has been a median 0.9% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (72 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: CHD vs CLX CLX vs REYN CENT vs CLX

More: Household Products stocks compared, Consumer Staples sector, rankings of US companies

Figures from Clorox's SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Clorox.